L. van der Putten
VU University Medical Center
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by L. van der Putten.
American Journal of Neuroradiology | 2012
M.H. Verhappen; Petra J. W. Pouwels; Redina Ljumanovic; L. van der Putten; Dirk L. Knol; R. de Bree; J. A. Castelijns
BACKGROUND AND PURPOSE: Several studies have reported on the clinical utility of DWI in head and neck cancer, but none of these studies compared HASTE with EPI-DWI in patients with head and neck cancer. The aim of our study was to compare detection and delineation of primary tumors and lymph nodes by using HASTE and EPI-DWI techniques in patients with HNSCC. MATERIALS AND METHODS: Twelve patients with HNSCC and a total of 12 primary tumors and 77 visualized lymph nodes on MR imaging underwent DWI by using both EPI-based and HASTE techniques. Interobserver agreement for detection, delineation, and ADC values of primary tumors and lymph nodes was assessed by 2 radiologists, and artifacts for both DWI techniques were described. RESULTS: The number of lesions (primary tumors and lymph nodes) identified on pretreatment EPI-DWI was higher compared with pretreatment HASTE-DWI, with means of total lesions of 88.5 and 69.0, respectively. Delineation of lesions was also better on pretreatment EPI-DWI compared with pretreatment HASTE-DWI, with means of well-delineated lesions of 80.5 and 27.5, respectively. Both EPI- and HASTE-DWI showed good interobserver agreement between radiologists of ADC values in lesions with ICC values of 0.79 and 0.92, respectively. Intraobserver agreement for ADC values in lesions assessed with EPI- versus HASTE-DWI techniques was low, with ICC values of 0.31 and 0.42, respectively. Significant interobserver disagreement concerning detection was only seen with HASTE-DWI, and none of the DWI techniques showed significant interobserver disagreements regarding delineation. EPI-DWI was more prone to susceptibility artifacts than HASTE-DWI: Ninety-one percent of primary tumors and 16% of lymph nodes were affected by susceptibility artifacts on pretreatment EPI-DWI, whereas these artifacts were not seen on HASTE-DWI. CONCLUSIONS: Primary tumors and lymph nodes are more easily visualized on EPI-DWI compared with HASTE-DWI. EPI-DWI has geometric distortion, however, which has a negative effect on interobserver agreement of ADC values.
Molecular Imaging and Biology | 2008
L. van der Putten; Otto S. Hoekstra; R. de Bree; Dirk J. Kuik; Emile F.I. Comans; Johannes A. Langendijk; Charles R. Leemans
PurposeTo evaluate accuracy and interobserver variability in the assessment of 2-deoxy-2[F-18]fluoro-d-glucose-positron emission tomography (FDG-PET) for detection of recurrent laryngeal carcinoma after radiotherapy.ProceduresEleven experienced nuclear physicians from eight centres assessed 30 FDG-PET scans on the appearance of local recurrence (negative/equivocal/positive). Conservative (equivocal analysed as negative) and sensitive (equivocal analysed as positive) assessment strategies were compared to the reference standard (recurrence within 6months after PET).ResultsSeven patients had proven recurrences. For the conservative and sensitive strategy, the mean sensitivity was 87% and 97%, specificity 81% and 63%, positive predictive values 61% and 46% and negative predictive values 96% and 99%, respectively. Interobserver variability showed a reasonable relation in comparison to the reference standard (kappa = 0.55).ConclusionsFDG-PET has acceptable interobserver agreement and yields good negative predictive value for detection of recurrent laryngeal carcinoma. It could therefore be used as first diagnostic step and may reduce futile invasive diagnostics.
Clinical Otolaryngology | 2011
L. van der Putten; R. de Bree; Dirk J. Kuik; P. Doornaert; Simone E. J. Eerenstein; C.R. Leemans
Clin. Otolaryngol. 2011, 36, 37–44
Case Reports | 2013
L. van der Putten; E. Bloemena; P Merkus; Ef Hensen
Temporal bone Schneiderian papilloma may present as a primary tumour originating from the middle ear and mastoid process, or an extension from sinonasal disease. Both forms are rare, this being only the 18th case of primary temporal bone Schneiderian papilloma described to date. Although the current patient has remained disease free after excision of the papilloma, the reported recurrence rate is high, comparable to sinonasal Schneiderian papilloma with extrasinus extension. Malignant progression of primary Schneiderian papillomas is significantly reduced as compared to Schneiderian papillomas that extend from the sinonasal tract into the temporal bone. A positive human papilloma virus status, as found in this case, is a common feature and prognostic factor of sinonasal Schneiderian papilloma but an infrequent finding in temporal bone disease. Owing to the high recurrence rate, the risk of malignant progression and the absence of reliable prognostic markers, stringent follow-up consisting of otoscopy, nasendoscopy and imaging is essential.
Oral Oncology | 2011
L. van der Putten; R. de Bree; Dirk J. Kuik; D. Rietveld; Jan Buter; Simone E. J. Eerenstein; C.R. Leemans
Radiotherapy and Oncology | 2004
L. van der Putten; R. de Bree; John Plukker; Fred R. Burlage; Cas Smits; C.R. Leemans; Johannes A. Langendijk
Radiotherapy and Oncology | 2017
M.X. Qu; Vikram Velker; Eric Leung; Janice S. Kwon; Mohamed A. Elshaikh; Iwa Kong; N. Logie; Lucas C. Mendez; L. van der Putten; Elysia Donovan; Adnan R. Munkarah; E.M. Wiebe; Alexander V. Louie; David D'Souza
Value in Health | 2015
R. Zaim; L. van der Putten; S. de Groot; H. van Tinteren; Maarten Boers; Emile F.I. Comans; van der Bernard Laan; Luuk M. Janssen; Robert P. Takes; M.W.M. van den Brekel; Wim J.G. Oyen; R.A. Valdés-Olmos; Monique G.G. Hobbelink; Jan Wedman; Charles R. Leemans; Otto S. Hoekstra; R. de Bree; Ca Uyl-de Groot
Archive | 2012
L. van der Putten; R. Spasiano; R. de Bree; Giulia Bertino; C. René Leemans; Marco Benazzo; Policlinico S. Matteo
Radiotherapy and Oncology | 2010
R. de Bree; L. van der Putten; Otto Hoekstra; Dirk J. Kuik; Emile F.I. Comans; C.R. Leemans